Exploiting protein stability changes to identify next generation chemical probes and target engagement technologies
Exploiting protein stability changes to identify next generation chemical probes and target engagement technologies
批准号:
RGPIN-2022-03107
负责人:
Page, Brent
金额:
$2.7万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background My research focusses on cutting-edge chemical biology and medicinal chemistry projects that prioritize the concept of "target engagement" - the direct physical interaction of chemical probes with their cellular target. Major aims within this program include developing innovative target engagement technologies and using them to study interactions between chemical probes and their target proteins. Additionally, this program includes an innovative new approach to produce targeted protein degraders (proteolysis targeting chimeras, PROTACs). Objectives and Approach Long-term goal: My research program aims to produce target engagement technologies and PROTACs that are used to explore complex biological phenomena. These tools will allow us to develop a better understanding of our target proteins, such as STAT1, STAT3, CNOT3 and TK1. Further, our novel target engagement technologies will have far-reaching effects within chemical probe discovery, facilitating the development of future generations of chemical probes. Short-term Objectives: 1.Optimize protocols for producing target engagement biosensors within our CeTEAM platform My research team has generated a novel target engagement technology called "CeTEAM" - Cellular Target Engagement by Accumulation of Mutant. This technique uses a biosensor approach for target engagement that is high-throughput and does not require an external stimulus, such as heat. We have demonstrated that CeTEAM biosensors can effectively indicate if an endogenous target protein is engaged by a chemical probe. Within this objective we will expand our repertoire of CeTEAM biosensors and focus on optimizing our process for CeTEAM biosensor development. 2.Develop novel target engagement assays that exploit unique aspects of E. coli biology To improve throughput and reduce barriers to implementation, we have turned to non-mammalian systems for investigating cellular target engagement. In this objective we aim to exploit unique aspects of E. coli biology to produce a novel target engagement technique called LIBR-TEA (ligand-induced Inclusion Body Rescue - Target Engagement Assay, "liberty"). 3. Exploit small biomolecules to produce targeted degraders as chemical biology tools As a highly innovative approach to PROTACs, we will employ naturally occurring biomolecules to target our PROTACs to proteins of interest. As a proof of concept study, we have developed thymidine-inspired PROTACs to target thymidine kinase 1 (TK1) and demonstrated that they can reduce TK1 protein levels in cells. This objective will focus on optimizing bio-inspired PROTACs for TK1 and other targets. Impact Our novel target engagement techniques and new approach to PROTAC development is set to have a transformative impact on the chemical biology field. These tools will allow us to develop a better understanding of complex biological systems and will facilitate the discovery and validation of future chemical probes and targeted degraders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploiting protein stability changes to identify next generation chemical probes and target engagement technologies
-
批准号:DGECR-2022-00171
-
项目类别:Discovery Launch Supplement
-
资助金额:$0.91万
-
财政年份:2022
-
负责人:Page, Brent
-
依托单位:
Stat3 Inhibitors
-
批准号:410649-2011
-
项目类别:Alexander Graham Bell Canada Graduate Scholarships - Doctoral
-
资助金额:$2.55万
-
财政年份:2012
-
负责人:Page, Brent
-
依托单位:
Stat3 Inhibitors
-
批准号:410649-2011
-
项目类别:Alexander Graham Bell Canada Graduate Scholarships - Doctoral
-
资助金额:$2.55万
-
财政年份:2011
-
负责人:Page, Brent
-
依托单位:
Medicinal inorganic chemistry
-
批准号:370725-2008
-
项目类别:University Undergraduate Student Research Awards
-
资助金额:$0.33万
-
财政年份:2008
-
负责人:Page, Brent
-
依托单位:
medicinal inorganic chemistry
-
批准号:352812-2007
-
项目类别:University Undergraduate Student Research Awards
-
资助金额:$0.33万
-
财政年份:2007
-
负责人:Page, Brent
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: